HLF activators constitute a distinct chemical class of compounds known for their ability to modulate the activity of the HLF (Hepatic Leukemia Factor) protein, a transcription factor with essential roles in regulating gene expression. HLF belongs to the basic helix-loop-helix (bHLH) family of transcription factors and plays a pivotal role in various cellular processes, including circadian rhythm regulation and embryonic development. These activators are designed to interact with HLF and enhance its transcriptional activity, influencing the expression of target genes that are under the control of this transcription factor. At the molecular level, the mechanisms underlying HLF activation are intricate and often involve binding to specific regions of the HLF protein, potentially inducing conformational changes that enhance its DNA-binding and transactivation capabilities.
The study of HLF activators is instrumental in advancing our understanding of the regulatory networks governed by HLF and its downstream effects on gene expression. Researchers in this field primarily focus on elucidating the precise molecular mechanisms by which these activators impact HLF's function, shedding light on the intricate transcriptional control of genes involved in circadian rhythms and development. Understanding the role of HLF activators contributes to our broader knowledge of gene regulation and its significance in various biological contexts, from the synchronization of biological clocks to the orchestration of key developmental processes. Moreover, these compounds provide valuable tools for scientists seeking to investigate the molecular mechanisms that underlie these fundamental biological phenomena, ultimately deepening our understanding of cellular and developmental biology.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Diethylstilbestrol | 56-53-1 | sc-204720 sc-204720A sc-204720B sc-204720C sc-204720D | 1 g 5 g 25 g 50 g 100 g | $71.00 $287.00 $547.00 $1098.00 $2185.00 | 3 | |
Synthetic estrogen that can modulate gene expressions; potential influence on HLF through estrogenic pathways. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor; might influence HLF expression by altering DNA methylation patterns. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Another DNA methyltransferase inhibitor; might influence HLF expression by changing DNA methylation. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Histone deacetylase inhibitor; potential effects on HLF expression through chromatin remodeling. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Also a histone deacetylase inhibitor; might affect HLF expression by altering chromatin accessibility. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor; potential indirect effects on HLF expression due to its influence on protein degradation. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Kinase inhibitor; might modulate signaling pathways that intersect with HLF expression. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Tyrosine kinase inhibitor; potential indirect effects on HLF expression through kinase signaling pathways. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
JAK inhibitor; might influence JAK-STAT signaling and, in turn, HLF expression. | ||||||
Everolimus | 159351-69-6 | sc-218452 sc-218452A | 5 mg 50 mg | $131.00 $651.00 | 7 | |
mTOR inhibitor; might influence pathways that regulate HLF expression. | ||||||